Abirapro 250 mg Tablet, containing abiraterone acetate, is a medication primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) in men. It works by inhibiting the production of androgens (male hormones like testosterone), which can fuel the growth of prostate cancer cells. Abirapro is prescribed for men with prostate cancer that has spread to other parts of the body and is no longer responding to standard hormonal therapies. ​It is often used alongside corticosteroids like prednisolone to manage potential side effects such as high blood pressure and low potassium levels.Unlike traditional chemotherapy, Abirapro is a hormonal therapy that targets the underlying mechanisms of cancer growth, providing an alternative treatment pathway.